TickerFactsScreenerDevelopers

PUMA BIOTECHNOLOGY, INC. (PBYI) — Cost of Revenue

Annual figures by fiscal year, from SEC filings.

2017: $5.57M2018: $34.62M2019: $36.81M2020: $39.37M2021: $63.70M2022: $55.09M2023: $62.68M2024: $64.40M2025: $58.16M$58.16M
2017Cost of Revenue (USD)2025
Fiscal YearCost of RevenueChange YoY
2025$58.16M-9.7%
2024$64.40M+2.7%
2023$62.68M+13.8%
2022$55.09M-13.5%
2021$63.70M+61.8%
2020$39.37M+7.0%
2019$36.81M+6.3%
2018$34.62M+521.3%
2017$5.57M—